Add Yahoo as a preferred source to see more of our stories on Google. A blood sample for an HIV test is available at the Checkpoint BLN laboratory. The development of the HIV infection-preventing drug ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

An HIV patient in Oslo has been in remission for the past five years following a stem cell transplant from his brother, who was found to be resistant to the virus, marking what could only be the 10th ...

Worldwide, nearly half of new HIV infections among adults in 2019 occurred in women. Yet a long list of obstacles has kept many women from taking advantage of medicine that can prevent an HIV ...

A computer visualization of the human immunodeficiency virus (HIV). Credit: Centers for Disease Control and Prevention Several early Phase 1 human trials of vaccines using mRNA technology are now ...

The 12th IAS Conference on HIV Science took place in Brisbane, Australia from July 23 to 26. (Photo by RODRIGO ARANGUA / AFP) (Photo credit should read RODRIGO ARANGUA/AFP via Getty Images) As ...

The gel releases a steady dose of the anti-HIV drug lamivudine over six weeks, suggesting people living with HIV could have new therapy that doesn't require a daily pill regimen to prevent AIDS. A new ...

For only the second time in recorded medical history, a man’s HIV infection has gone into remission. The patient — positive for the virus that causes AIDS since 2003 — had received a blood stem cell ...

Kane Race (left) and Kairon Liu (right) discussing Untransmittable. Credit: Beau Newham, courtesy of The National Association of People with HIV Australia (NAPWHA) This past July, the 12th ...